You just read:

Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Submits NDA To FDA For Narcan® (naloxone) Nasal Spray

News provided by

Lightlake Therapeutics Inc.

Jul 29, 2015, 09:00 ET